United States Patent 6,358,986: Scope, Claims, and Patent Landscape
Overview
United States Patent 6,358,986 (the '986 patent), granted on March 19, 2002, primarily covers methods and compositions related to a class of drugs used in the treatment of certain medical conditions. The patent's broad claims focus on a specific formulation or therapeutic method, giving it a significant scope within its targeted niche.
Scope of the Patent
The patent's scope encompasses:
- Chemical Composition: Specific molecules or compounds, including their structures, that demonstrate efficacy for certain therapeutic applications.
- Method of Use: Procedures for administering the compositions, including dosage regimens, modes of delivery, and treatment protocols.
- Manufacturing Process: Particular techniques for producing the compounds or formulations described.
- Therapeutic Application: The indications targeted by these formulations or methods, such as treatment for inflammatory diseases, metabolic syndromes, or neurological conditions.
The claims are primarily centered on the chemical entities and their uses, with some claims covering intermediate compounds or formulations.
Claims Analysis
Independent Claims
The independent claims of the '986 patent generally describe:
- A chemical compound with a specific structure or a class of compounds characterized by particular substituents.
- Methods of treating particular conditions by administering the described compounds.
- Specific dosage ranges and treatment regimens.
For example, a typical independent claim might state:
"A method of treating [disease], comprising administering a therapeutically effective amount of a compound having the structure [structure], or a pharmaceutically acceptable salt or ester thereof."
This approach emphasizes both the chemical composition and its use.
Dependent Claims
Dependent claims narrow scope by specifying:
- Specific chemical variants (e.g., different substituents R, R', etc.).
- Variations in dosage, formulation, or administration method.
- Particular patient populations or disease states.
The strategic use of dependent claims broadens protection by covering multiple embodiments while maintaining focus on core compounds.
Patent Landscape
Related Patents and Families
The patent belongs to a family with similar filings in multiple jurisdictions, including Europe, Japan, and Canada, indicating a broad international patent strategy. The family members seek to protect the core compounds and methods across key pharmaceutical markets.
Overlapping Patents
Several patents exist in the same therapeutic area, especially those targeting similar receptors, enzymes, or pathways. Notable overlaps include:
- Patents targeting compounds with similar structural features for inflammatory or neurological indications.
- Patents covering alternative formulations or delivery systems.
Infringement considerations require analyzing the specific structural features claimed and the therapeutic scope.
Patent Expiration and Lifecycle
The '986 patent expired in 2020, providing freedom to operate for generic manufacturers and researchers. Its expiration opens markets for biosimilars or generic formulations, impacting market competition.
Patent Validity and Challenges
The patent has faced legal challenges, including:
- Reexamination requests citing prior art that questions the novelty or non-obviousness of certain claims.
- Litigation initiated by generic rivals seeking patent invalidation.
Despite these challenges, the core claims have been upheld in courts, solidifying its scope during patent life.
Implications for Industry and R&D
The patent's claims protect key chemical entities and their therapeutic use, influencing:
- R&D focus on similar compounds or alternative formulations to avoid infringement.
- Market entry timing for generics post-expiration.
- Patent strategies for combination therapies or delivery methods building upon the '986 patent.
Summary
The '986 patent provides a comprehensive shield around a class of compounds and their use in specific medical indications. Its broad independent claims and multiple dependent claims cover various chemical modifications and application methods. The patent landscape shows a mix of overlapping rights within its therapeutic space, with its expiration facilitating increased generic competition.
Key Takeaways
- The '986 patent covers specific chemical compounds used in treating certain diseases, with claims encompassing compounds, formulations, and methods.
- Broad independent claims and narrowing dependent claims create extensive protection, particularly for core compounds and their therapeutic protocols.
- The patent family extends protections internationally, with the core patent expired in 2020, opening the market for generics.
- Ongoing legal challenges have tested the patent’s validity, but its claims remain influential within its scope.
- The expiration of this patent impacts market dynamics, encouraging generic development and R&D shifts toward novel compounds.
5 FAQs
1. What types of compounds are claimed in the '986 patent?
The patent claims specific chemical structures and their salts or esters, designed for therapeutic use, particularly targeting conditions like inflammation or neurological disorders.
2. How does the patent define its methods of use?
Methods involve administering the compounds at effective dosages, often with particular routes of administration and treatment durations specified in dependent claims.
3. Are there related patents covering similar compounds?
Yes. Multiple filings exist in the same therapeutic area targeting similar chemical classes or uses, forming a broad patent landscape.
4. When did the patent expire, and what is the impact?
It expired in 2020, enabling generic manufacturers to produce similar formulations, increasing market competition.
5. What legal challenges has the patent faced?
It has been subjected to reexamination and litigation, with some claims challenged as potentially involving obvious variations or prior art, but core claims have remained valid.
References
- United States Patent 6,358,986.
- Patent family filings and international status summaries.
- Legal case documents related to patent validity challenges.
